Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1991-12-2
|
pubmed:abstractText |
In the present study, we investigated the effects of human recombinant interleukin-7 (IL-7) on the proliferation of enriched hematopoietic cells isolated from human adult and fetal bone marrow (BM). In cultures of CD34+ cells, IL-7 was found to induce dose-dependent incorporation of 3H-thymidine (3H-TdR), but had no demonstrable effect on the development of myeloid colony-forming cells. Numbers of B-cell precursors (BCP), initially present within CD34+ populations and which included a CD34+CD20+ subset, were significantly increased when CD34+ BM cells were cultured in the presence of IL-7. This effect was most striking on CD20+ BCP, and resulted at least partly from higher numbers of cycling cells as indicated by Hoechst 33342 fluorescence (Calbiochem, Behring Diagnostics, La Jolla, CA). These results indicate that IL-7 promotes the growth of BCP within the CD34+ compartment. In line with the B-lineage affiliation of CD34+ target cells, committed BCP (CD10+ CD19+ surface IgM-) isolated from BM were also found to proliferate in response to IL-7. Interestingly, this effect of IL-7 was strongly potentiated by the addition of IL-3. Taken together, and in accordance with previous observations on murine cells, our data indicate that IL-7 acts as a growth factor during the ontogeny of human B lymphocytes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-3,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-7
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2229-38
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1718491-Adult,
pubmed-meshheading:1718491-Antigens, CD,
pubmed-meshheading:1718491-Antigens, CD34,
pubmed-meshheading:1718491-B-Lymphocytes,
pubmed-meshheading:1718491-Base Sequence,
pubmed-meshheading:1718491-Bone Marrow,
pubmed-meshheading:1718491-Bone Marrow Cells,
pubmed-meshheading:1718491-Cell Division,
pubmed-meshheading:1718491-Cells, Cultured,
pubmed-meshheading:1718491-Cloning, Molecular,
pubmed-meshheading:1718491-DNA,
pubmed-meshheading:1718491-Drug Synergism,
pubmed-meshheading:1718491-Flow Cytometry,
pubmed-meshheading:1718491-Hematopoietic Stem Cells,
pubmed-meshheading:1718491-Humans,
pubmed-meshheading:1718491-Interleukin-3,
pubmed-meshheading:1718491-Interleukin-7,
pubmed-meshheading:1718491-Molecular Sequence Data
|
pubmed:year |
1991
|
pubmed:articleTitle |
Interleukin-7 induces the proliferation of normal human B-cell precursors.
|
pubmed:affiliation |
Schering-Plough, Laboratory for Immunological Research, Dardilly, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|